Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
12/30/1998 | WO1998058677A1 Pharmaceutical formulations containing voriconazole |
12/30/1998 | WO1998058668A2 Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae |
12/30/1998 | WO1998058652A1 Stable aspirin ointment preparations |
12/30/1998 | WO1998058651A1 Stable aspirin-containing preparations for external use |
12/30/1998 | WO1998058629A2 Preparation of pharmaceutical compositions |
12/30/1998 | WO1998044944A3 Stabilized human papillomavirus formulations |
12/30/1998 | WO1998044936A3 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations |
12/30/1998 | WO1998043497A3 Oral compositions having enhanced mouthfeel |
12/30/1998 | EP0887072A1 Use of sulfites and meta bisulfites, for the manufacturing of cosmetic or pharmaceutical compositions, principally for dermatologig, having an inhibitory effect on melanogenesis or skin whitening |
12/30/1998 | EP0886680A1 Virus-like particle |
12/30/1998 | EP0886654A1 Thioureido-cyclodextrins particularly useful for solubilising antitumoral and antiparasitic agents, and methods for preparing same |
12/30/1998 | EP0886652A1 Pulmonary surfactant peptide solubilization process |
12/30/1998 | EP0886649A1 Protein occlusion for delivery of small molecules |
12/30/1998 | EP0886518A1 Water soluble pharmaceutical coating and method for producing coated pharmaceuticals |
12/30/1998 | EP0886474A1 Caramels containing a sweetener |
12/30/1998 | EP0886471A1 Methods and compositions for inducing oral tolerance in mammals |
12/30/1998 | EP0801570A4 Formulations and methods for reducing skin irritation |
12/30/1998 | EP0737201A4 Backbone modified oligonucleotide analogs and solid phase synthesis thereof |
12/30/1998 | EP0731785B1 Ceramide 3 derivatives based on monounsaturated fatty acids |
12/30/1998 | EP0723432B1 Free flowing emulsion concentrate |
12/30/1998 | EP0686142B1 Polyamine derivatives as radioprotective agents |
12/30/1998 | EP0633945B1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN |
12/30/1998 | EP0553244B1 Targeted immunostimulation with bispecific reagents |
12/30/1998 | EP0523184B1 Oil speil recovery method |
12/30/1998 | CN1203527A Stable freeze-dried pharmaceutical formulation |
12/30/1998 | CN1041436C Method for stabilizing rheumatism-traumatic medicinal liquor |
12/30/1998 | CN1041419C Process for preparation of mitomycin C-dextran |
12/30/1998 | CA2294611A1 Complexes for transporting nucleic acid into higher eukaryotic cells |
12/30/1998 | CA2294348A1 Vaccines containing bordetella pertussis antigen |
12/30/1998 | CA2264022A1 Stable aspirin-containing preparations for external use |
12/29/1998 | US5854382 Bioresorbable compositions for implantable prostheses |
12/29/1998 | US5854281 Preparation for percutaneous absorption |
12/29/1998 | US5854270 Oral compositions containing ondansetron |
12/29/1998 | US5854246 Topical ketoconazole emulsions |
12/29/1998 | US5854226 Pharmaceutical composition |
12/29/1998 | US5854225 Compounds derived from cyclodextrin |
12/29/1998 | US5854223 S-DC28 as an antirestenosis agent after balloon injury |
12/29/1998 | US5854208 Hepatoselective pharmaceutical actives |
12/29/1998 | US5853758 Preparation of tablets of increased strength |
12/29/1998 | US5853753 Liposomes, method of preparing the same and use thereof in the preparation of drugs |
12/29/1998 | US5853752 Methods of preparing gas and gaseous precursor-filled microspheres |
12/29/1998 | US5853751 Molecular transdermal transport system |
12/29/1998 | US5853748 Pharmaceutical compositions |
12/29/1998 | US5853736 Potentiation of immunogenic response |
12/29/1998 | US5853732 Pharmaceutical compositions containing kukui nut oil |
12/29/1998 | US5853723 Targeting of peg antibody conjugates to islet cells |
12/29/1998 | US5853713 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
12/29/1998 | US5853616 Method for preparing low-concentration polyaluminosilicate microgels |
12/29/1998 | CA2158583C Pharmaceutical composition in the form of a kit |
12/29/1998 | CA2143413C Local drug delivery film, for periodontal treatment |
12/29/1998 | CA1340297C Conjugation of polymer to colony stimulating factor-1 |
12/24/1998 | DE19726264A1 Preparation of homogeneous, stable, water-free formulation(s) |
12/24/1998 | DE19725615A1 Zur topischen Applikation bestimmte Diclofenac-Lösung For topical application specific diclofenac solution |
12/24/1998 | DE19724868A1 Stable cosmetic or pharmaceutical preparation, e.g. cream |
12/24/1998 | DE19724696A1 Pharmazeutische Zubereitung mit drei Pelletarten Pharmaceutical composition with three pellet types |
12/24/1998 | DE19724670A1 Inkorporation von pharmakologisch wirksamen Aminosäureanaloga in Proteine Incorporation of pharmacologically active amino acid analogues into proteins |
12/23/1998 | WO1998058258A1 Formulation for immunological reaction systems |
12/23/1998 | WO1998057662A2 Therapeutic systems |
12/23/1998 | WO1998057646A1 Aqueous medicinal preparations for external use containing solubilized difluprednate |
12/23/1998 | WO1998057630A1 Pharmaceutical form for administering paclitaxel, method for preparing a ready-for-use paclitaxel composition and thereof |
12/23/1998 | WO1998057625A2 Composition for controlling oxidation-reduction |
12/23/1998 | WO1998057624A1 Diclofenac solution for topical application |
12/23/1998 | WO1998041535A3 Activation of peptides |
12/23/1998 | EP0885900A2 Increasing blood-brain barrier permeability with permeabilizer peptide derivatives of bradykinin |
12/23/1998 | EP0885393A1 Graphitic nanotubes in luminescence assays |
12/23/1998 | EP0885277A1 Substantially linear ethylene/alpha-olefin polymers as viscosity index improvers or gelling agents |
12/23/1998 | EP0885189A2 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
12/23/1998 | EP0885060A1 Solid and semi-solid hydrocarbon gels and uses thereof |
12/23/1998 | EP0885016A1 Thermally stabilized contrast agent |
12/23/1998 | EP0885015A2 Modified cytokines for therapeutic use |
12/23/1998 | EP0885014A1 Pharmaceutical compositions containing buffered ortho ester polymers |
12/23/1998 | EP0885010A1 Intercellular adhesion molecule powder formulation |
12/23/1998 | EP0885002A2 Materials and methods for enhancing cellular internalization |
12/23/1998 | EP0759741B1 Mucoadhesive emulsions containing cyclodextrin |
12/23/1998 | EP0728012A4 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF |
12/23/1998 | EP0719146B1 Novel method of progesterone delivery and effect thereof |
12/23/1998 | EP0607222B1 Dendrimeric polychelants |
12/23/1998 | EP0553294B1 The manufacture of compositions for the treatment of cell proliferation disorders |
12/23/1998 | EP0473721B1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
12/23/1998 | EP0471792B1 Methods, reagents and test kits for determination of subpopulations of biological entities |
12/23/1998 | EP0321464B1 Coatings based on polydextrose for aqueous film coating of pharmaceutical, food and confectionery products |
12/23/1998 | CN1202903A Targeted cytotoxic anthracycline analogs |
12/23/1998 | CN1202829A Method for preserving microoganisms |
12/23/1998 | CN1202827A 1,2,4-benzotriazine oxides formulations |
12/23/1998 | CN1202819A Composition for transdermal delivery |
12/23/1998 | CN1041281C Polymer-bound taxol derivatives |
12/23/1998 | CA2292608A1 Therapeutic systems for activation prodrugs |
12/22/1998 | US5852055 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof |
12/22/1998 | US5852002 Treatment of conditions and disease |
12/22/1998 | US5851992 Treatment of growth hormone deficiency |
12/22/1998 | US5851989 Method of extending the plasma half-life of vascular endothelial cell growth factor |
12/22/1998 | US5851818 Condensed plasmid-liposome complex for transfection |
12/22/1998 | US5851791 Ubiquitin conjugating enzyme (E2) fusion proteins |
12/22/1998 | US5851670 In vivo-soluble composite particles comprising calcium phosphate |
12/22/1998 | US5851546 Polymer composition for controlled release of active ingredients in response to pH, and a process of preparing the same |
12/22/1998 | US5851543 Skin care preparation and method |
12/22/1998 | US5851536 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures |
12/22/1998 | US5851527 Method for antibody targeting of therapeutic agents |
12/22/1998 | US5851526 Methods of treating colon cancer utilizing tumor-specific antibodies |
12/22/1998 | US5851517 Composition including a dispersion of polymer particles in a non-aqueous medium |